67 related articles for article (PubMed ID: 30899411)
1. PDCD5 inhibits osteosarcoma cell metastasis via targeting TGF-β1/Smad signaling pathway and is associated with good prognosis.
Zhao H; Peng C; Lu X; Guo M; Yang T; Zhou J; Hai Y
Am J Transl Res; 2019; 11(2):1116-1128. PubMed ID: 30899411
[TBL] [Abstract][Full Text] [Related]
2. The mechanism of VCP-mediated metastasis of osteosarcoma based on cell autophagy and the EMT pathway.
Li AA; Zhang Y; Li F; Zhou Y; Liu ZL; Long XH
Clin Transl Oncol; 2023 Mar; 25(3):653-661. PubMed ID: 36284060
[TBL] [Abstract][Full Text] [Related]
3. Wedelolactone suppresses breast cancer growth and metastasis via regulating TGF-β1/Smad signaling pathway.
Li H; Hou M; Zhang P; Ren L; Guo Y; Zou L; Cao J; Bai Z
J Pharm Pharmacol; 2024 Jun; ():. PubMed ID: 38848454
[TBL] [Abstract][Full Text] [Related]
4. The metastasis suppressor CD82/KAI1 regulates cell migration and invasion via inhibiting TGF-β 1/Smad signaling in renal cell carcinoma.
Zhu J; Liang C; Hua Y; Miao C; Zhang J; Xu A; Zhao K; Liu S; Tian Y; Dong H; Zhang C; Li P; Su S; Qin C; Wang Z
Oncotarget; 2017 Aug; 8(31):51559-51568. PubMed ID: 28881668
[TBL] [Abstract][Full Text] [Related]
5. Moscatilin Reverses EMT Progression and its Resulting Enhanced Invasion and Migration by Affecting the TGF-β Signaling Pathway in Bladder Cancer.
Li Z; Yang J; Chen L; Chen P; Liu C; Long X; Chen B; Long J
Anticancer Agents Med Chem; 2024 May; ():. PubMed ID: 38808719
[TBL] [Abstract][Full Text] [Related]
6. Carboxypeptidase Vitellogenic-Like Promotes the Proliferation and Metastasis of Osteosarcoma through the TGF-β/Smad Signaling Pathway.
Wang L; Piao L; Yuan X; Tong L; Han X; Wang J; Shi D; Shao S; Xu X; Zhuang M; Cheng D; Liu Z
Ann Clin Lab Sci; 2023 Nov; 53(6):890-904. PubMed ID: 38182149
[TBL] [Abstract][Full Text] [Related]
7. Oral TGF-βR1 inhibitor Vactosertib promotes osteosarcoma regression by targeting tumor proliferation and enhancing anti-tumor immunity.
Choi SH; Myers J; Tomchuck S; Bonner M; Eid S; Kingsley D; VanHeyst K; Kim SJ; Kim BG; Huang AY
Res Sq; 2023 Apr; ():. PubMed ID: 37066414
[TBL] [Abstract][Full Text] [Related]
8. Hypermethylated PODN represses the progression of osteosarcoma by inactivating the TGF-β/Smad2/3 pathway.
Han X; Zhang Y; Lu F; Feng J; Zhang C; Wang G
Pathol Res Pract; 2022 Oct; 238():154075. PubMed ID: 36037657
[TBL] [Abstract][Full Text] [Related]
9. Activation of the TGF-β1/EMT signaling pathway by claudin-1 overexpression reduces doxorubicin sensitivity in small cell lung cancer SBC-3 cells.
Nagaoka Y; Oshiro K; Yoshino Y; Matsunaga T; Endo S; Ikari A
Arch Biochem Biophys; 2024 Jan; 751():109824. PubMed ID: 37984759
[TBL] [Abstract][Full Text] [Related]
10. Biological effect of ETV4 and the underlying mechanism of its regulatory effect on epithelial‑mesenchymal transition in intrahepatic cholangiocarcinoma cells.
Liu L; Feng Y; Xiang X; Xu M; Tang G
Oncol Lett; 2024 Aug; 28(2):346. PubMed ID: 38872859
[TBL] [Abstract][Full Text] [Related]
11. USP9X inhibits metastasis in pulmonary sarcomatoid carcinoma by regulating epithelial-mesenchymal transition, angiogenesis and immune infiltration.
Feng Q; Liu Q; Liu Z; Xu J; Yang Y; Zhu Y; Lu G; Xu G; Wu D; Wang F; Liu B; Wang W; Ding X
Transl Oncol; 2024 Jul; 47():101950. PubMed ID: 38964032
[TBL] [Abstract][Full Text] [Related]
12. Identification of Osteosarcoma Metastasis-Associated Gene Biomarkers and Potentially Targeted Drugs Based on Bioinformatic and Experimental Analysis.
Cao MD; Song YC; Yang ZM; Wang DW; Lin YM; Lu HD
Onco Targets Ther; 2020; 13():8095-8107. PubMed ID: 32884293
[TBL] [Abstract][Full Text] [Related]
13. Correction to: The mechanism of VCP‑mediated metastasis of osteosarcoma based on cell autophagy and the EMT pathway.
Li AA; Zhang Y; Li F; Zhou Y; Liu ZL; Long XH
Clin Transl Oncol; 2024 Feb; 26(2):558-560. PubMed ID: 38070052
[No Abstract] [Full Text] [Related]
14. Editorial: Angiogenesis and tumor metastasis.
Zhang QZ; Zhu YP; Rahat MA; Kzhyshkowska J
Front Oncol; 2022; 12():1129736. PubMed ID: 36733363
[No Abstract] [Full Text] [Related]
15. Lgr5-mediated p53 Repression through PDCD5 leads to doxorubicin resistance in Hepatocellular Carcinoma.
Ma Z; Guo D; Wang Q; Liu P; Xiao Y; Wu P; Wang Y; Chen B; Liu Z; Liu Q
Theranostics; 2019; 9(10):2967-2983. PubMed ID: 31244936
[TBL] [Abstract][Full Text] [Related]
16. Prognostic potentials of miRNA-19a-3p and PDCD5 in nasopharynx carcinoma.
Zhong JH; Zhong JJ; Shi YN; Hu XM; Xu MJ; Guo Z; Zhong TY; Li WS; Wang Y
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11114-11119. PubMed ID: 33215428
[TBL] [Abstract][Full Text] [Related]
17. Cardiac Fibrosis Mitigated by an Endogenous Negative Regulator of HDAC.
Lazaropoulos MP; Elrod JW
Circ Res; 2023 Jul; 133(3):252-254. PubMed ID: 37471486
[No Abstract] [Full Text] [Related]
18. COL5A2 Inhibits the TGF-β and Wnt/β-Catenin Signaling Pathways to Inhibit the Invasion and Metastasis of Osteosarcoma.
Han YL; Luo D; Habaxi K; Tayierjiang J; Zhao W; Wang W; Aikebaier W; Wang L
Front Oncol; 2022; 12():813809. PubMed ID: 35280775
[TBL] [Abstract][Full Text] [Related]
19. The Secretome of Human Neonatal Mesenchymal Stem Cells Modulates Doxorubicin-Induced Cytotoxicity: Impact in Non-Tumor Cells.
Serras AS; Camões SP; Antunes B; Costa VM; Dionísio F; Yazar V; Vitorino R; Remião F; Castro M; Oliveira NG; Miranda JP
Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884877
[TBL] [Abstract][Full Text] [Related]
20. Lycorine inhibits tumor growth of human osteosarcoma cells by blocking Wnt/β-catenin, ERK1/2/MAPK and PI3K/AKT signaling pathway.
Yuan XH; Zhang P; Yu TT; Huang HK; Zhang LL; Yang CM; Tan T; Yang SD; Luo XJ; Luo JY
Am J Transl Res; 2020; 12(9):5381-5398. PubMed ID: 33042426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
